Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies
Wai-Kay Seto, Department of Medicine, the University of Hong Kong, Queen Mary Hospital, Hong Kong, China
Wai-Kay Seto, Department of Medicine, the University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, Guangdong Province, China
Wai-Kay Seto, State Key Laboratory for Liver Research, the University of Hong Kong, Hong Kong, China
Author contributions: Seto WK interpreted the literature and wrote the manuscript.
Conflict-of-interest statement: Wai-Kay Seto is an advisory board member and received speaker’s fees from AbbVie; he is also an advisory board member, received speaker’s fees and research funding from Gilead Sciences.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Wai-Kay Seto, FRCP (C), MBBS, MD, Associate Professor, Doctor, Department of Medicine, the University of Hong Kong Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China. firstname.lastname@example.org
Telephone: +86-852-22553994 Fax: +86-852-28162863
Received: August 29, 2018
Peer-review started: August 29, 2018
First decision: October 9, 2018
Revised: October 14, 2018
Accepted: October 21, 2018
Article in press: October 21, 2018
Published online: January 21, 2019